Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 3/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25741470 | 0.95 | AHR (0.34) | AHRESR2ESR1 | |
| SCHEMBL25741471 | 0.91 | DNM1 (0.31) | AHR | |
| SCHEMBL23634656 | 0.89 | AHR (0.34) | AHRKDM4EATML3MBTL1ALOX5 | |
| SCHEMBL23625905 | 0.89 | AHR (0.32) | AHR | |
| SCHEMBL23634596 | 0.87 | KDM4E (0.35) | AHRKDM4EATML3MBTL1MEN1 | |
| SCHEMBL26534918 | 0.86 | AHR (0.35) | AHRKDM4EATML3MBTL1 | |
| SCHEMBL23634626 | 0.83 | MEN1 (0.31) | MEN1KMT2A | |
| SCHEMBL23634676 | 0.82 | KDM4E (0.35) | AHRESR2ESR1KDM4EATM | |
| SCHEMBL23634640 | 0.81 | KDM4E (0.36) | KDM4EATML3MBTL1ALOX5ALDH1A1 | |
| SCHEMBL25741461 | 0.80 | AHR (0.40) | AHRESR2ESR1KDM4EL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11680071-B2 | Compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2023-06-20 | — | — | US | disclosed |
| US-11680071-B2 | Compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2023-06-20 | — | — | US | disclosed |
| US-20210214369-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2021-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210214369-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | NCOA4, NR2E3, NR4A1 | AHR 65/4885ESR2 263/4885ESR1 76/4885 |
| US-11680071-B2 | Compound and organic light emitting device comprising the same | NCOA4, NR2E3, NCOA1 | AHR 43/4885ESR2 298/4885ESR1 94/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.